NASDAQ:RMTI - Rockwell Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.20 +0.16 (+5.26 %)
(As of 12/13/2018 08:43 AM ET)
Previous Close$3.04
Today's Range$3.07 - $3.33
52-Week Range$2.88 - $6.92
Volume223,292 shs
Average Volume197,789 shs
Market Capitalization$173.21 million
P/E Ratio-6.27
Dividend YieldN/A
Rockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company's lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company's target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.

Receive RMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
Current SymbolNASDAQ:RMTI
Previous Symbol


Debt-to-Equity RatioN/A
Current Ratio2.53
Quick Ratio2.16


Trailing P/E Ratio-6.27
Forward P/E Ratio-5.61
P/E GrowthN/A

Sales & Book Value

Annual Sales$57.30 million
Price / Sales3.18
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.64 per share
Price / Book5.00


EPS (Most Recent Fiscal Year)($0.51)
Net Income$-25,920,000.00
Net Margins-53.40%
Return on Equity-117.31%
Return on Assets-55.39%


Outstanding Shares56,980,000
Market Cap$173.21 million

Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

How were Rockwell Medical's earnings last quarter?

Rockwell Medical Inc (NASDAQ:RMTI) issued its quarterly earnings results on Friday, November, 9th. The company reported ($0.10) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.05. The business had revenue of $16.67 million for the quarter, compared to the consensus estimate of $15 million. Rockwell Medical had a negative net margin of 53.40% and a negative return on equity of 117.31%. View Rockwell Medical's Earnings History.

When is Rockwell Medical's next earnings date?

Rockwell Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 21st 2019. View Earnings Estimates for Rockwell Medical.

What price target have analysts set for RMTI?

1 brokers have issued 1 year target prices for Rockwell Medical's shares. Their forecasts range from $11.00 to $11.00. On average, they anticipate Rockwell Medical's stock price to reach $11.00 in the next twelve months. This suggests a possible upside of 243.8% from the stock's current price. View Analyst Price Targets for Rockwell Medical.

What is the consensus analysts' recommendation for Rockwell Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rockwell Medical.

Has Rockwell Medical been receiving favorable news coverage?

Press coverage about RMTI stock has trended neutral on Thursday, InfoTrie reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Rockwell Medical earned a media sentiment score of 0.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the stock's share price in the next few days.

Who are some of Rockwell Medical's key competitors?

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the folowing people:
  • Dr. Ajay Gupta, Chief Scientific Officer & Member of Scientific Advisory Board (Age 60)
  • Dr. Raymond Dennis Pratt, Chief Medical Officer (Age 67)
  • Mr. Stuart Paul, Pres, CEO & Director
  • Mr. Angus W. Smith, Chief Financial Officer (Age 35)
  • Mr. David Kull, Principal Accounting Officer & Controller (Age 51)

Who are Rockwell Medical's major shareholders?

Rockwell Medical's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.26%), TIAA CREF Investment Management LLC (0.17%), Bridgeway Capital Management Inc. (0.18%), Sigma Investment Counselors Inc. (0.17%), Rehmann Capital Advisory Group (0.11%) and Balasa Dinverno & Foltz LLC (0.07%). Company insiders that own Rockwell Medical stock include David S Richmond and Kenneth L Holt. View Institutional Ownership Trends for Rockwell Medical.

Which major investors are selling Rockwell Medical stock?

RMTI stock was sold by a variety of institutional investors in the last quarter, including TIAA CREF Investment Management LLC and Balasa Dinverno & Foltz LLC. View Insider Buying and Selling for Rockwell Medical.

Which major investors are buying Rockwell Medical stock?

RMTI stock was bought by a variety of institutional investors in the last quarter, including Bridgeway Capital Management Inc., Jefferies Group LLC, BlackRock Inc., Virtu Financial LLC, Sigma Investment Counselors Inc. and Rehmann Capital Advisory Group. View Insider Buying and Selling for Rockwell Medical.

How do I buy shares of Rockwell Medical?

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $3.20.

How big of a company is Rockwell Medical?

Rockwell Medical has a market capitalization of $173.21 million and generates $57.30 million in revenue each year. The company earns $-25,920,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis. Rockwell Medical employs 300 workers across the globe.

What is Rockwell Medical's official website?

The official website for Rockwell Medical is

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 30142 S WIXOM RD, WIXOM MI, 48393. The company can be reached via phone at 248-960-9009 or via email at [email protected]

MarketBeat Community Rating for Rockwell Medical (NASDAQ RMTI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  225 (Vote Outperform)
Underperform Votes:  264 (Vote Underperform)
Total Votes:  489
MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe RMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2018 by Staff

Featured Article: Stop Order

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel